The effect of MKK4 variants on cancer susceptibility has been assessed in CRC (28, 33), lung cancer (24), acute myeloid leukemia (34), nasopharyngeal carcinoma (35), cervical cancer (36), and breast cancer (37). The gene discussed is MAP2K4; the disease is colorectal carcinoma.